Lack of Association between Using Aspirin and Development of Non-Hodgkins Lymphoma: A Meta-analysis |
Cheraghi, Maria
(Social Determinants of Heath Research Center, School of Public Heath, Ahvaz Jundishapur University of Medical Sciences)
Amoori, Neda (Abadan School of Medical Sciences) Fallahzadeh, Hosein (Department of Biostatic and Epidemiology, Shahid Sadoughi University of Medical Sciences) Rahmani, Hossein (Department of Toxicology, Shahreza Branch, Islamic Azad University, Shahreza, and Medical Research Center, Jundishapur Health Development Co.) |
1 | Amanat A, Al-Belushi B, I Waly M, Al-Moundhri M, A Burney Ik (2013). Dietary and lifestyle factors and risk of non-Hodgkin's lymphoma in Oman. Asian Pac J Cancer Prev, 14, 841-8. DOI ScienceOn |
2 | Amoori N, Mirzaei M, Cheraghi M(2014). Incidence of cancers in Kuzestan province of Iran: trend from 2004 to 2008. Asian Pac J Cancer Prev, 15, 8345-9. DOI |
3 | Ansell SM, Armitage J (2005). Non-Hodgkin lymphoma: diagnosis and treatment. Proc Mayo Clinic, 80, 1087-97. DOI |
4 | Baker JA, Weiss JR, Czuczman MS, et al (2005). Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control, 16, 301-8. DOI |
5 | Baecklund E, Iliadou A, Askling J, et al (2006). Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum, 54, 692-701. DOI |
6 | Binesh F, Akhavan A, Behniafard N, Atefi A (2014). Clinicopathologic and survival characteristics of childhood and adolescent non Hodgkin's lymphoma in Yazd, Iran. Asian Pac J Cancer Prev, 15, 1585-8. DOI |
7 | Boffetta P, de Vocht F (2007). Occupation and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 16, 369-72. DOI |
8 | Broccia G, Cocco P, Casula P (2001). Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993. Haematologica, 86, 58-63. |
9 | Cerhan JR, Anderson KE, Janney CA, et al (2003). Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer, 106, 784-8. DOI |
10 | Chang ET, Smedby KE, Hjalgrim H, et al (2005). Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol, 162, 965-74. DOI |
11 | Chia SE, Wong KY, Tai BC (2012). Occupation and risk of non-Hodgkin's lymphoma in Singapore. Occup Med, 62, 29-33. DOI |
12 | Clarke CA, Glaser SL(2002). Changing incidence of nonhodgkin lymphomas in the United States. Cancer. 94, 2015-23. DOI ScienceOn |
13 | Devesa SS, Fears T (1992). Non-Hodgkin's lymphoma time trends: United States and international data. Cancer research, 52, 5432-40. |
14 | Erber E, Lim U, Maskarinec G, Kolonel LN(2009). Common immune-related risk factors and incident non-Hodgkin lymphoma: The multiethnic cohort. Int J Cancer, 125, 1440-5. DOI |
15 | Ekstrom-Smedby K (2006). Epidemiology and etiology of non-Hodgkin lymphoma--a review. Acta Oncol, 45, 258-71. DOI |
16 | Flick ED, Chan KA, Bracci PM, Holly EA (2006). Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol, 497, 164-504. |
17 | Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O (2009). Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica, 94, 647-53. DOI |
18 | Hernandez BY, Green MD, Cassel KD, et al (2010). Cancer Research Center Hotline: Preview of Hawai 'i Cancer Facts and Figures 2010. Hawaii Med J, 69, 223. |
19 | Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI |
20 | Hoshida Y, Xu J-X, Fujita S, et al (2007). Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medicatio. J Rheumatol, 34, 322-31.n |
21 | Karami K, Cheraghi M, Amori N, Pedram M, Sobhani A (2014). Common cancers in Khuzestan province, South West of Iran, during 2005-2011. Asian Pac J Cancer Prev, 15, 9475-8. DOI |
22 | Kato I, Koenig KL, Shore RE, et al (2002). Use of antiinflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL)(United States). Cancer Causes Control, 13, 965-74. DOI |
23 | Rothwell PM, Fowkes FGR, Belch JF, et al (2011). Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet, 377, 31-41. DOI |
24 | Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, et al (2012). Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet, 379, 1602-12. DOI |
25 | Sangrajrang S, Renard H, Kuhaprema T, et al (2011). Personal use of hair dyes--increased risk of non-Hodgkin's lymphoma in Thailand. Asian Pac J Cancer Prev, 12, 2393-6. |
26 | Setoguchi S, Solomon DH, Weinblatt ME, et al (2006). Tumor necrosis factor antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum, 54, 2757-64. DOI |
27 | Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics. CA Cancer J Clin, 61, 212-36. DOI |
28 | Teras LR, Gapstur SM, Patel AV, et al (2013). Aspirin and other nonsteroidal anti-inflammatory drugs and risk of non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 22, 422-8. DOI |
29 | Thun MJ, Jacobs EJ, Patrono C (2012). The role of aspirin in cancer prevention. Nat Rev Clin Oncol, 9, 259-67. DOI ScienceOn |
30 | Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2006). Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs. Cancer Detect Prev, 30, 99-101. DOI |
31 | Zekri AR, Hassan ZK, Bahnassy AA et al (2013). Gene expression profiling of non-Hodgkin lymphomas. Asian Pac J Cancer Prev, 14, 4393-8. DOI |
32 | Zelenetz AD, Abramson JS, Advani RH, et al (2010). Non-Hodgkin's lymphomas. J Nat Compr Cancer Netw, 8, 288-334. |
33 | Yildirim M, Karakilinc H, Yildiz M, et al (2013). Non-Hodgkin lymphoma and pesticide exposure in Turkey. Asian Pacific J Cancer Prev, 14, 3461-3. DOI ScienceOn |